BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intercept Pharmaceuticals 



New York City  New York    U.S.A.
Phone: n/a Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Intercept Pharmaceuticals (ICPT) To Present At Upcoming Investor Conferences 8/26/2014 7:21:23 AM
Intercept Pharmaceuticals (ICPT) Soars As Liver Drug Found Effective In Mid-Stage Trial 8/12/2014 6:07:48 AM
Intercept Pharmaceuticals (ICPT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/11/2014 4:55:21 PM
Intercept Pharmaceuticals (ICPT) Names Lazar Partners Agency Of Record 7/10/2014 10:44:00 AM
Intercept Pharmaceuticals (ICPT) To Present At Upcoming Investor Conferences 6/6/2014 9:34:15 AM
Intercept Pharmaceuticals (ICPT) Announces That FDA Grants Fast Track Designation To Obeticholic Acid For The Treatment Of Patients With Primary Biliary Cirrhosis 5/29/2014 9:09:47 AM
Intercept Pharmaceuticals (ICPT) Reports Additional Positive OCA Data In Patients With Bile Acid Diarrhea At Digestive Disease Week 5/7/2014 9:15:46 AM
Intercept Pharmaceuticals (ICPT) Appoints Rachel Mcminn, Ph.D. As Chief Strategy Officer 4/30/2014 3:53:09 PM
Intercept Pharmaceuticals (ICPT) Reports Additional Positive Data From POISE Trial At EASL Late-Breaker Session 4/14/2014 6:37:05 AM
Intercept Pharmaceuticals (ICPT) Announces Preclinical Data Demonstrating OCA's Potential Role In Preventing Complications Of Cirrhosis 4/11/2014 6:59:17 AM
1234567